See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/275342605

Flavonols flavones flavanones and human health - epidemiological evidence

Data · April 2015

CITATIONS READS
13 2,025

3 authors:

Brigitte A. Graf Paul E Milbury

Manchester Metropolitan University Tufts University
44 PUBLICATIONS 1,596 CITATIONS 73 PUBLICATIONS 5,588 CITATIONS

SEE PROFILE SEE PROFILE

Jeffrey B. Blumberg
Tufts University
368 PUBLICATIONS 24,222 CITATIONS

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

Diet, skin colour, health and attractive and healthy appearance View project

Effect of Gamma- oryzanol as therapeutic to prevent Cardiorenal Metabolic Syndrome in animals submitted to high sugar-fat diet View project

All content following this page was uploaded by Paul E Milbury on 23 April 2015.

The user has requested enhancement of the downloaded file.

JOURNAL OF MEDICINAL FOOD
J Med Food 8 (3) 2005, 281–290
© Mary Ann Liebert, Inc. and Korean Society of Food Science and Nutrition

Mini-Review

Flavonols, Flavones, Flavanones, and Human Health: Epidemiological Evidence

Brigitte A. Graf, Paul E. Milbury, and Jeffrey B. Blumberg
Antioxidants Research Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging,
Tufts University, Boston, Massachusetts

ABSTRACT Polyphenolic flavonoids are among a wide variety of phytochemicals present in the human diet. Basic research,
animal model, and human studies suggest flavonoid intake may reduce the risk of several age-related chronic diseases. The
vast number of flavonoids and mixtures of their subclasses, including flavonols, flavones, and flavanones, and the variety of
agricultural practices that affect their concentration in foods have presented a challenge to the development of adequate food
composition databases for these compounds. Nonetheless, dietary assessments have been applied to cohort and case-control
epidemiological studies, and several reveal an inverse association with risk of some forms of cancer, cardiovascular disease,
and other chronic conditions. Those observational studies that have examined these relationships with regard to flavonols,
flavones, and flavanones are reviewed. The requirement for caution in interpreting these studies is discussed with regard to
the limited information available on the bioavailability and biotransformation of these flavonoids. As the totality of the avail-
able evidence on these flavonoids suggests a role in the prevention of cancer and cardiovascular disease, further research is
warranted, particularly in controlled clinical trials.

KEY WORDS: • cancer • coronary heart disease • epidemiological evidence • flavanones • flavones • flavonoids •
flavonols

INTRODUCTION serve as antioxidants against the pro-oxidant effects of ul-

traviolet light,7 and act against bacterial, fungal, and viral
pathogens as well as some insect predators.8 Human con-
O BSERVATIONAL STUDIES consistently report inverse rela-
tionships between fruit and vegetable consumption and
many degenerative diseases, such as cancer and heart dis-
sumption of flavonoids is significant not only via plant
foods9,10 but also via intake of plant extracts such as tea,
ease.1–5 However, epidemiological methods do not readily coffee, and red wine.11 Average flavonoid intakes in selected
reveal which compounds in these food groups are responsi- countries are shown in Table 1.
ble for these health benefits; indeed, compounds potentially Flavonoids are most commonly divided into six sub-
responsible for significant contributions to such outcomes classes, based on the connection position of the B and C
include several vitamins and minerals, soluble and insolu- rings as well as the degree of saturation, oxidation, and hy-
ble fibers, and phytochemicals such as the carotenoids and droxylation of the C ring, as flavonols, flavones, flavanones,
indoles. Increasing attention has recently been focused on flavan-3-ols (or catechins), isoflavones, and anthocyanidins
polyphenolic compounds, particularly the flavonoids. (Figs. 1 and 2). Examples of some structures of individual
Flavonoids are synthesized by all vascular plants and are flavonoids of each group are presented in Table 2. The con-
present throughout our diet in fruits, vegetables, nuts, seeds, tent of individual flavonoids and flavonoid subclasses in
herbs, spices, and whole grains. Within the plant, flavonoids foods can vary markedly, even between similar foods.9,22
are involved in electron transport during photosynthesis,6 As a result, diverse dietary patterns can provide consider-
ably different intakes of these nutrients. Examples of the
principal flavonoids present in some common foods are pro-
Manuscript received 22 November 2004. Revision accepted 22 February 2005. vided in Table 3.
Address reprint requests to: Dr. Jeffrey B. Blumberg, Antioxidants Research Laboratory, This review focuses on epidemiological studies investi-
Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, 711 gating health effects of flavonols, flavones, and flavanones.
Washington Street, Boston, MA 02111, E-mail: [email protected]
In considering this literature, it is important to keep in mind
This work was presented in part at the 2004 Annual Meeting of the Korean Society of the very limited information available in nutrient databases
Food Science and Nutrition and the International Symposium on The Current Prospects
of Functional and Medicinal Food, held in Jeju Island, South Korea, 17–19 November
about these compounds, e.g., among the flavonols, results
2004. are limited almost exclusively to quercetin, kaempferol, and

281
282 GRAF ET AL.

TABLE 1. ESTIMATED DIETARY INTAKE OF FLAVONOIDS IN DIFFERENT COUNTRIES

Intake (mg/day)

Country Population Flavonols Flavones Flavanones Catechins Anthocyanidins Isoflavones Sum Reference

Scotland n  81 19.0 0.1 1.0 59.0 79.1 Duthie

(4-day weighed intake) et al.12
Wales n  1,900 men 26.3 26.3 Hertog
45–59 years old et al.13
(FFQ; weighed dietary
intake)
Finland n  10,054 4.0 1.0 20.0 24.0 Knekt
39  16 years old et al.14
(diet history)
Holland n  4,807, 26.6 26.6 Geleijnse
67.4  7.8 years old et al.15
(FFQ)
The n  806 men, 72.0 72.0 Arts
Netherlands 65–84 years old et al.16
(diet history)
United n  34,789 men, 19.9 0.2 20.1 Rimm
States 40–75 years old et al.17
(FFQ)
United n  38,445 women, 23.9 0.7 24.6 Sesso
States 45 years old et al.18
(FFQ)
United n  34,492, 13.8 0.1 13.9 Yochum
States 55–69 years old et al.19
(Iowa) (FFQ)
Japan n  115 women, 16.0 1.0 47 63.0 Arai
29–78 years old et al.20
(diet history)
Germany n  119, 13.1 0.1 21.1 11.0 6.6 51.9 Linseisen
(Bavaria) 19–49 years old et al.21
(7-day diet protocols)

No study provided values for all subclasses of flavonoids; hence listed values are likely underestimated. FFQ, Food Frequency
Questionnaire. Estimates are based on incomplete tables of flavonoid aglycones in foods (in mg/day).

myricetin. As reviews on the potential health benefits of the CARDIOVASCULAR DISEASE (CVD)
isoflavones25,26 and catechins16,27,28 have been published re-
cently, these flavonoid classes are not covered in this report. Seven high-quality epidemiological studies have reported
Absent useful databases of the anthocyanidin content of on the effects of dietary flavonol, flavone, and flavanone in-
common foods, little epidemiological information is avail- take and CVD (Table 4). Two Dutch studies, the Rotterdam
able about this class of flavonoids. Study15 and the Zutphen Elderly Study29,30 observed inverse
correlations between the intake of these flavonoids and CVD
incidence. After a 5.6-year follow-up, The Rotterdam Study15
found a 65% reduction in the relative risk for non-fatal my-
ocardial infarction (MI) in a cohort of 4,807 subjects
55
years old, but only a non-significant 7% reduction in the risk
for fatal MI. The Zutphen Elderly Study, a 10-year follow-
up of 805 men 65–84 years old,29,30 reported a significant re-
duction in the relative risk of CVD mortality in the highest
quartile of daily intake (
30 mg) of flavonols and flavones;
while this level of intake also predicted a 38% lower inci-
dence of first MI, this association was not statistically signif-
icant. In contrast, the Finnish Mobile Clinic Health Exami-
FIG. 1. Basic structure and numbering system of flavonoids. nation Survey,14 a 28-year follow-up study with
10,000
Flavonoids contain two aromatic rings (A and B) that are linked via subjects, found no significant correlation between flavonol,
an oxygenated heterocycle (ring C). flavone, and flavanone intakes and CVD mortality. However,
 HEALTH EFFECTS OF FLAVONOIDS 283

TABLE 3. FLAVONOID CONTENT OF SELECTED FOODS

Flavonoid Content
subclass Food source (mg/100 g)

Flavonols Onion, raw 15.4

Broccoli, raw 9.4
Apples 4.4
Black grapes 3.0
Flavones Celery, raw 5.9
Parsley, raw 303.2
Thyme, fresh 56.0
Flavan-3-ols Apples 9.1
Red wine 11.9
Green tea 132.1
Black tea 34.3
Flavanones Oranges 43.9
Lemons 49.8
Grapefruit 54.5
Anthocyanidins Blueberries 112.5
Raspberries 47.6
Red wine 9.2
Red onion 13.1
Isoflavones Soymilk 9.6
Tofu 28.1

Quantity of six flavonoid subclasses in the edible portion of

foods, taken from the USDA Database for the Flavonoid Con-
tent of Selected Foods23 except for isoflavone values, which are
derived from the Iowa State University Database on the
Isoflavone Content of Foods.24
FIG. 2. Subclasses of flavonoids. Individual flavonoids are struc-
turally distinct because of different patterns of hydroxylation, methy-
lation, and conjugation with various mono- and disaccharides.

TABLE 2. STRUCTURES OF INDIVIDUAL FLAVONOIDS

Substituents
Flavonoid
subclass Flavonoid 3 5 7 3 4 5

Flavonols Quercetin OH OH OH OH OH H
Kaempferol OH OH OH H OH H
Myricetin OH OH OH OH OH OH
Flavones Apigenin H OH OH H OH H
Luteolin H OH OH OH OH H
Flavan-3-ols Catechin OH OH OH OH OH H
Epigallocatechin OH OH OH OH OH OH
Epigallocatechin G OH OH OH OH OH
gallate
Flavanones Hesperetin H OH OH OH OCH3 H
Naringenin H OH OH H OH H
Eriodictyol H OH OH OH OH H
Anthocyanidins Cyanidin OH OH OH OH OH H
Malvidin OH OH OH OCH3 OH OCH3
Petunidin OH OH OH OCH3 OH OH
Isoflavones Genistein H* OH OH H OH H
Daidzein H* H OH H OH H

Individual molecular structures of flavonoids are determined by the addition of hydroxyl, methyl, and methoxy groups, most
commonly at position 3, 5, 7, 3, 4, or 5 on the flavonoid nucleus. The number and positioning of hydroxyl groups together with
the degree of saturation of the C ring determine the antioxidant capacity of individual flavonoids. G  gallate. H* indicates that in
the case of isoflavones, H is attached to position 2, because of the connection of the C and B rings at position 3.
284 GRAF ET AL.

TABLE 4. EFFECT OF DIETARY FLAVONOIDS ON CORONARY HEART DISEASE (CHD) INCIDENCE—EPIDEMIOLOGICAL STUDIES
Flavonoid intake Compared Relative risk (95%
Country Study population (per day) with Incident confidence interval) Reference

The Rotterdam Study: n  4807,
33 mg flavonolsa 23 mg MI 0.76 (0.49, 1.18)b Geleijnse
Netherlands 55 years old Fatal MI 0.93 (0.57, 1.52)b et al.15
(mean 67.4  7.8 years old), Non-fatal MI 0.35 (0.13, 0.98)c
5.6-year follow-up
The Zutphen Elderly Study: 30 mg flavonols and 19 mg CHD mortality 0.47 (0.27, 0.82)c Hertog
Netherlands n  805 men, flavonesd et al.29,30
65–84 years old, First MI 0.62 (0.24, 1.05)b
10-year follow-up
Wales Caerphilly Study:
34 mg flavonolsa 19 mg IHD 1.6 (0.9, 2.9)b Hertog
n  1,900 men, et al.13
45–59 years old,
14-year follow-up
Finland Finnish Mobile Clinic Health
33 mg flavonols, 6 mg IHD mortality 0.93 (0.74, 1.17)b Knekt
Examination Survey: flavones, flavanonese et al.14
n  10,054,
4.3 mg quercetin 1.7 mg IHD mortality 0.79 (0.63, 0.99)c

15 years old,
0.9 mg kaempferol 0.2 mg IHD mortality 0.82 (0.66, 1.02)b
28-year follow-up
0.2 mg myricetin 0 mg IHD mortality 1.14 (0.92, 1.40)b

21 mg hesperetin 2 mg IHD mortality 0.95 (0.76, 1.19)b

6 mg naringenin 0.5 mg IHD mortality 0.98 (0.78, 1.22)b
United States Woman’s Health Study: 47 mg flavonols and 9 mg CVD 0.88 (0.68, 1.14)b Sesso
n  38,445, flavones (median)d (median) et al.18
45 years old,
6.9-year follow-up
33 mg quercetin 7 mg CVD 0.96 (0.74, 1.25)b
(median) (median)
United States n  34,492 women,
29 mg flavonols and 4 mg Fatal CVD 0.62 (0.44, 0.87)b Yochum
(Iowa) 55–69 years old, flavones (median)d (median) et al.19
10-year follow-up

19 mg quercetin 3 mg Fatal CVD 0.74 (0.52, 1.06)b
(median) (median)
United States Health Professionals
40 mg flavonols and 7 mg Non-fatal MI 1.08 (0.81, 1.43)b Rimm
Follow-up: flavonesd et al.17
n  34,789 men, Non-fatal MI 0.63 (0.33–1.20)b
40–75 years old, with history
5-year follow-up of CHD

Results are adjusted for confounding factors, but methods of adjustment varied in different studies. Results from Hirvionen et al.31
and The Seven Country Study (Hertog et al.32) are not included in the above table as data on the statistical significance were not
shown or data collection and statistical analysis were different. CVD, cardiovascular disease; IHD, ischemic heart disease; MI, my-
ocardial infarction.
aSum of quercetin, kaempferol, and myricetin (flavonols).
bNot significant result.
cSignificant result.
dSum of quercetin, kaempferol, myricetin (flavonols), luteolin, and apigenin (flavones).
eSum of quercetin, kaempferol, myricetin, isorhamnetin (flavonols), apigenin, luteolin (flavones), hesperetin, naringenin, and

eriodictyol (flavanones).

when these data were limited only to intake of the flavonol founded by other variables, such as the strong association
quercetin, CVD mortality was significantly reduced by 21% between tea drinking and smoking in this population; fur-
in those with a daily intake
4 mg. ther, tea provided 82% of total flavonoid intake in this co-
In contrast, three large cohort studies in the United States, hort where essentially all the tea was consumed with milk.13
each with
34,000 participants, were unable to identify a While milk has been suggested to impair the bioavailability
significant correlation for dietary flavonoid intake and CVD of flavonoids, several small intervention trials have failed to
incidence.17–19 The discrepancy between these sets of stud- confirm this effect.33–36
ies may be explained, in part, on the younger ages, greater The analysis by Hertog et al.32 of the Seven Country
ratio of women to men, and/or other lower risk factors in Study revealed that varying flavonoid intake might partially
the U.S. cohorts. Results from the Caerphilly Study in 1,900 explain different rates of disease incidence and mortality in
Welsh men, 45–59 years old, which found a non-significant different countries. They reported that 8% of the between-
60% increase in CVD risk with flavonol intake, may be con- country variation of CVD mortality was explained by a high
 HEALTH EFFECTS OF FLAVONOIDS 285

intake of dietary flavonols, while intake of saturated fat ex- CANCER

plained 73% and smoking 9% of the variation.
It is important to keep in mind that each of these epidemi- Results from observational studies of flavonoid intake
ological studies was based exclusively on dietary assessments, and cancer are mixed (Table 6). Examining the Caerphilly
with all the limitations imposed by these methods, without val- Study, Hertog et al.13 found a non-significant 30% in-
idation of exposure by biomarkers, such as the concentration crease in all-cause cancer mortality associated with a daily
of flavonoids (and/or their active metabolites) in plasma or tar- flavonol intake of
34 mg. Hertog et al.40 also reported
get tissues. Such investigations are warranted in future stud- a non-significant increase in cancer incidence in the Zut-
ies and may also provide needed information about the impact phen Elderly Study. In contrast, results from the much
of nutrient–nutrient interactions and inter-individual differ- larger Netherlands Cohort Study on Diet and Cancer with
ences affecting flavonoid bioavailability. 120,852 subjects followed for 4.3 years provided no cor-
relation between flavonoid intake and cancer incidence.39
CEREBROVASCULAR DISEASE However, with its 28-year follow-up, the Finnish Mobile
Clinic Health Examination Survey obtained a significant
To date, four major epidemiological studies have inves- inverse correlation between flavonol, flavone, and fla-
tigated the effect of flavonol, flavone, and/or flavanone in- vanone intake and the incidence of lung cancer.14 When
take on cerebrovascular disease (Table 5). The results are these data were focused solely on quercetin, intake of
4
equivocal as two studies support the hypothesis that these mg daily was associated with a significant 23% reduction
flavonoids reduce the risk of stroke while two others report in cancer incidence.
no effect.14,19,31,37 The potential importance of long-term Some case-control studies suggest that high intakes of
flavonoid intake is underscored here as the two studies sug- quercetin may reduce the incidence of esophageal and stom-
gesting a protective action employed a follow-up of 15–28 ach cancers,41,44 though a similar effect has not been observed
years, whereas those with a null association examined this for lung cancer.42,43 Future studies that examine biomarkers
relationship for 10 years. of oxidative DNA injury and genetic susceptibility to cancer

TABLE 5. EFFECT OF DIETARY FLAVONOIDS ON STROKE INCIDENCE—EPIDEMIOLOGICAL STUDIES

Relative risk
Flavonoid intake Compared (95% confidence
Country Study population (per day) with Incidence interval) Reference

The Zutphen Study:
29 mg flavonols 18 mg Stroke 0.27 (0.11, 0.70)b Keli
Netherlands n  552 men, and flavonesa et al.37
50–69 years old,
15-year follow-up
Finland Finnish Mobile Clinic
33 mg flavonols, 6 mg Cerebrovascular disease 0.79 (0.64, 0.98)b Knekt
Health Examination flavones, et al.14
Survey: n  10,054, flavanonesc

15 years old,
4.3 mg quercetin 1.7 mg Cerebrovascular disease 0.86 (0.70, 1.05)d
28-year follow-up
0.9 mg kaempferol 0.2 mg Cerebrovascular disease 0.70 (0.56, 0.86)b

0.2 mg myricetin 0 mg Cerebrovascular disease 1.02 (0.84, 1.24)d

21 mg hesperetin 2 mg Cerebrovascular disease 0.80 (0.64, 0.99)b

6 mg naringenin 0.5 mg Cerebrovascular disease 0.79 (0.64, 0.98)b
Finland Alpha-Tocopherol
16 mg flavonols 4 mg Cerebral infarction 0.98 (0.80–1.21)d Hirvonen
Beta-Carotene Cancer and flavones (median) et al.38
Prevention Study: (median)a
n  26,593,
male smokers,
50–69 years old,
6.1-year follow-up
United States n  34,492 women,
29 mg flavonols 4 mg Stroke mortality 1.02 (0.59, 1.79)d Yochum
(Iowa) 55–69 years old, and flavones (median) et al.19
10-year follow-up (median)a
aSum of quercetin, kaempferol, myricetin (flavonols), luteolin, and apigenin (flavones).
bSignificant result.
cSum of quercetin, kaempferol, myricetin, isorhamnetin (flavonols), apigenin, luteolin (flavones), hesperetin, naringenin, and

eriodictyol (flavanones).
dNot significant result.

Results are adjusted for confounding factors, but methods of adjustment varied in different studies.
286 GRAF ET AL.

TABLE 6. EFFECT OF DIETARY FLAVONOIDS ON CANCER INCIDENCE—EPIDEMIOLOGICAL STUDIES

Flavonoid intake Compared Relative risk (95%
Country Study population (per day) with Incident confidence interval) Reference

Finland Finnish Mobile Clinic
33 mg flavonols, 6 mg All cancers 0.89 (0.74, 1.06)b Knekt
Health Examination flavones, flavanonesa Lung cancer 0.64 (0.39, 1.04)c et al.14
Survey: n  10,054, Colorectal cancer 0.84 (0.43, 1.64)b

15 years old, Breast cancer 1.23 (0.72, 2.10)b
28-year follow-up (in women)

4.3 mg quercetin 1.7 mg All cancers 0.77 (0.65, 0.92)c
Lung cancer 0.42 (0.25, 0.72)c
Colorectal cancer 0.62 (0.33, 1.17)b
Breast cancer 0.62 (0.37, 1.03)b
(in women)

0.9 mg kaempferol 0.2 mg All cancers 0.94 (0.78, 1.12)b
Lung cancer 0.81 (0.51, 1.28)b
Colorectal cancer 1.13 (0.60, 2.12)b
Breast cancer 0.87 (0.53, 1.41)b
(in women)

0.2 mg myricetin 0 mg All cancers 0.99 (0.83, 1.17)b
Lung cancer 1.20 (0.78, 1.83)b
Colorectal cancer 1.31 (0.71, 2.43)b
Breast cancer 0.95 (0.57, 1.60)b
(in women)

21 mg hesperetin 2 mg All cancers 0.96 (0.80, 1.15)b
Lung cancer 0.74 (0.46, 1.18)b
Colorectal cancer 0.97 (0.50, 1.90)b
Breast cancer 1.08 (0.63, 1.86)b
(in women)

6 mg naringenin 0.5 mg All cancers 0.96 (0.80, 1.15)b
Lung cancer 0.63 (0.40, 1.08)c
Colorectal cancer 0.93 (0.48, 1.82)b
Breast cancer 1.14 (0.67, 1.94)b
(in women)
Wales Caerphilly Study:
34 mg flavonolsd 19 mg All cancer 1.3 (0.7, 2.3)c Hertog
n  1,900 men, mortality et al.13
45–59 years old,
14-year follow-up
The Netherlands Cohort Study 44 mg flavonols and 13 mg Stomach cancer 0.86 (0.47, 1.57)b Goldbohm
Netherlands on Diet and Cancer: luteolin (median)e median Colorectal cancer 0.97 (0.71, 1.32)b et al.39
n  120,852, Lung cancer 0.99 (0.69, 1.42)b
55–69 years old, Breast cancer 1.02 (0.72, 1.44)b
4.3 year follow-up 30 mg quercetin 8 mg of Stomach cancer 1.08 (0.56, 2.05)b
(median) quercetin Colorectal cancer 1.06 (0.77, 1.45)b
(median) Lung cancer 0.81 (0.57, 1.17)b
Breast cancer 1.00 (0.70), 1.41)b
The Zutphen Elderly Study:
30 mg flavonols 19 mg All-cause cancer 1.21 (0.66, 2.21)b Hertog
Netherlands n  738 men, and flavonesf incidence et al.40
65–84 years old, Lung cancer 1.13 (0.38, 3.40)b
5-year follow-up incidence
All-cause cancer 1.43 (0.58, 3.54)b
death
Spain n  354 cases, Highest quartile of Lowest Stomach cancer 0.44 (0.25, 0.78)c Garcia-
354 controls flavonol and quartile Closas
luteolin intakee et al.41
Highest quartile of Lowest Stomach cancer 0.62 (0.35, 1.10)c
quercetin intake quartile
Spain n  103 cases, Highest tertile of Lowest Lung cancer 0.98 (0.44, 2.19)b Garcia-
206 controls flavonol and tertile Closas
mean age 63 years luteolin intakee et al.42

7 mg quercetin 2.5 mg of Lung cancer 0.99 (0.44, 2.23)b
quercetin
(continued)
 HEALTH EFFECTS OF FLAVONOIDS 287

TABLE 6. EFFECT OF DIETARY FLAVONOIDS ON CANCER INCIDENCE—EPIDEMIOLOGICAL STUDIES (CONTINUED)

Flavonoid intake Compared Relative risk (95%
Country Study population (per day) with Incident confidence interval) Reference

Hawaii n  582 cases,
69 mg flavonols 24 mg Lung cancer 0.80 (0.50, 1.40)b Le
582 controls, and flavones g Marchand
mean age 66.5 years
17 mg quercetin 9 mg Lung cancer 0.70 (0.40, 1.10)b et al.43
Uruguay n  111 cases, Highest quartile of Lowest Esophagus 0.47 (0.23, 0.93) De Stefani
444 controls quercetin intake quartile cancer et al.44
aSum of quercetin, kaempferol, myricetin, isorhamnetin (flavonols), apigenin, luteolin (flavones), hesperetin, naringenin, and
eriodictyol (flavanones).
bNot significant result.
cSignificant result.
dSum of quercetin, kaempferol, and myricetin (flavonols).
eSum of quercetin, kaempferol, myricetin (flavonols) and luteolin (flavones).
fSum of quercetin, kaempferol, myricetin (flavonols), luteolin, and apigenin (flavones).
gSum of quercetin, kaempferol, myricetin (flavonols), hesperetin, and naringenin (flavanones).

Results are adjusted for confounding factors, but methods of adjustment varied in different studies.

may better identify individuals and populations most re- tionship between flavonoid intake and a variety of chronic
sponsive to a potential chemopreventive action of flavonoids. diseases, including asthma, cataract, diabetes, and rheuma-
toid arthritis (Table 7). A diet rich in flavonols, flavones,
OTHER CHRONIC DISEASES and flavanones appeared to protect against asthma. Ex-
trapolating these data for quercetin revealed an statistically
Employing data from the Finnish Mobile Clinic Health significant inverse correlation with both asthma and dia-
Examination Survey, Knekt et al.14 examined the rela- betes.

TABLE 7. EFFECT OF DIETARY FLAVONOIDS ON ASTHMA, CATARACT, DIABETES, AND RHEUMATOID ARTHRITIS—EPIDEMIOLOGICAL STUDIES
Flavonoid Compared Relative risk (95%
Country Study population intake/day with Incident confidence interval)

Finland Finnish Mobile Clinic Health
33 mg flavonols, 6 mg Rheumatoid arthritis 1.18 (0.62, 2.26)b
Examination Survey: n  10,054, flavones, Diabetes 0.98 (0.77, 1.24)b
15 years old, flavanonesa Cataract 1.36 (0.84, 2.21)b
28-year follow-up Asthma 0.65 (0.47, 0.90)c

4.3 mg quercetin 1.7 mg Rheumatoid arthritis 2.64 (1.30, 5.36)b
Diabetes 0.81 (0.64, 1.02)c
Cataract 0.94 (0.57, 1.56)b
Asthma 0.76 (0.56, 1.01)c

0.9 mg kaempferol 0.2 mg Rheumatoid arthritis 1.91 (1.01, 3.62)c
Diabetes 0.92 (0.72, 1.18)b
Cataract 1.16 (0.69, 1.95)b
Asthma 0.86 (0.64, 1.14)b

0.2 mg myricetin 0 mg Rheumatoid arthritis 0.83 (0.44, 1.55)b
Diabetes 0.79 (0.62, 1.00)b
Cataract 1.10 (0.69, 1.76)b
Asthma 1.13 (0.86, 1.49)b

21 mg hesperetin 2 mg Rheumatoid arthritis 1.10 (0.59, 2.07)b
Diabetes 0.96 (0.76, 1.22)b
Cataract 1.66 (1.04, 2.66)b
Asthma 0.64 (0.46, 0.88)c

6 mg naringenin 0.5 mg Rheumatoid arthritis 0.99, (0.52, 1.88)b
Diabetes 0.98 (0.78, 1.24)b
Cataract 1.53 (0.95, 2.46)b
Asthma 0.69 (0.50, 0.94)b

Data are from Knekt et al.14 Results are adjusted for confounding factors.
aSum of quercetin, kaempferol, myricetin, isorhamnetin (flavonols), apigenin, luteolin (flavones), hesperetin, naringenin, and eri-

odictyol (flavanones).
bNot significant result.
cSignificant result.
288 GRAF ET AL.

DISCUSSION quercetin-4-glucoside, quercetin-3-glucoside) are more

Though certainly not definitive, the potential preventive readily absorbed than the major flavonols in green and black
action of flavonols, flavones, and flavanones against a va- tea (quercetin-3-rhamnoglucoside or rutin).47 Further com-
riety of chronic diseases reflects findings not only from ob- plexity to this matter is added by the apparently large inter-
servational studies but also from basic research studies of individual differences in flavonoid bioavailability and bio-
their multifunctional capabilities as antioxidants, chelators transformation.48,49
of transition metals, modulators of signal transduction path- Advances in observational studies may occur through the
ways, and other actions that may beneficially affect disease correlation of disease outcomes with flavonoid status in
etiology and pathophysiology.45 As with all investigations plasma and urine,50,51 although a better understanding and
of nutrients and health, a range of in vitro, cell culture, an- consideration of flavonoid pharmacokinetics are essential.
imal model, and human studies is necessary to fully under- Several studies have reported positive correlations between
stand the relationship between one or more related com- plasma and/or urinary concentrations of hesperetin,
pounds and the prevention of chronic diseases. While kaempferol, naringenin, and/or quercetin and their dietary
observational studies have proven a driving force in gener- intake through food or supplements.48,52–55 In contrast, Er-
ating many hypotheses about diet–health relationships, this lund et al.49,56 reported that hesperetin and naringenin sta-
approach is problematic for flavonoids and many other phy- tus in plasma and urine were not correlated with intake,
tochemicals. though such discrepancies may be accounted for by inter-
Analytic and descriptive epidemiological investigations individual differences or by use of different test foods. Be-
are critically dependent on an accurate measurement of food cause flavonoid concentrations in plasma are typically
intake through the use of dietary assessment instruments, cleared rapidly, levels in urine may prove a more reliable,
most often food frequency questionnaires in large cohort integrated biomarker of flavonoid intake.
studies. However, beyond the participants in the cohort or In conclusion, caution is warranted in the interpreta-
case-control groups completing these instruments accu- tion of epidemiological studies because accurate and
rately, this approach depends on inclusion of foods most rel- complete information about daily intake and bioavail-
evant to the hypothesis and validated nutrient databases. ability needs to be more fully developed. Nonetheless, the
With regard to assessing flavonoid intake, many food fre- available epidemiological studies, together with data
quency questionnaires are absent these items or fail to dis- from animal models and clinical trials, suggest that
tinguish sufficiently between important food sources, e.g., flavonoids, including flavonols, flavones, and flavanones,
types of berry fruit, red versus white wine, Camellia sinen- may beneficially affect disease etiology and pathophysi-
sis teas versus herb teas. As suggested by this review, the ology.
dietary assessment of flavonoid subclasses and even indi-
vidual flavonoids must be considered important as opposed
to earlier efforts examining total flavonoid intake to health REFERENCES
outcomes.
Because of the vast number of individual flavonoids, 1. Hu B: Vegetarian diets and risk of selected chronic diseases. Plant
often estimated at over 4,000 different compounds, the based foods and prevention of cardiovascular disease: An
lack of a truly comprehensive food composition database overview. Am J Clin Nutr 2003;78:544–551.
is not surprising. Further, the variation of flavonoids in 2. Riboli E, Norat T: Vegetarian diets and risk of selected chronic
foods and beverages is substantially dependent on factors diseases. Epidemiologic evidence of the protective effect of fruit
such as cultivar, growth conditions, ripeness, post-harvest and vegetables on cancer risk. Am J Clin Nutr 2003;78(Suppl):
processing, cooking, and storage.9,10,46 For example, yellow 559S–569S.
onions may contain between 9 and 81 mg of quercetin/ 3. World Cancer Research Fund in association with the American
Institute for Cancer Research: Food, Nutrition and the Prevention
100 g of fresh weight depending on the cultivar, and red
of Cancer: A Global Perspective, American Institute for Cancer
onions can contain up to 139 mg of quercetin/100 g.10,22
Research, New York, 1997.
Loss of flavonoids may also occur during food prepara-
4. Ness AR, Powles JW: Fruits and vegetables and cardiovascular
tion; though these compounds are relatively resistant to disease: A review. Int J Epidemiol 1997;26:1–13.
heat and stable in lightly fried vegetables, significant losses 5. Steinmetz KA, Potter JD: Vegetables, fruit and cancer prevention:
(up to 75%) may occur in cooking water because of their A review. J Am Diet Assoc 1996;96:1027–1039.
solubility.9,10 6. Das DK: Naturally occurring flavonoids: Structure, chemistry and
Complicating the difficulty of adequately determining high performance liquid chromatography methods for separation
flavonoid intake is the very limited information available on and characterization. Methods Enzymol 1994;234:410–420.
the bioavailability of these compounds and the suggestion 7. Jorgensen R: The origin of land plants: A union of algae and fun-
that the degree and rate of absorption from different food gus advanced by flavonoids? Biosystems 1993;31:193–207.
matrices may prove as or more important than the quantity 8. Havsteen BH: The biochemistry and medical significance of the
consumed. Illustrating this challenge is the fact that the flavonoids. Pharmacol Ther 2002;96:67–202.
principal flavonols in onion (quercetin-3,4-glucoside, 9. Crozier A, Lean MEJ, McDonald MS, Black C: Quantitative
 HEALTH EFFECTS OF FLAVONOIDS 289

analysis of the flavonoid content of commercial tomatoes, onions, 28. Blot WJ, McLaughlin JK, Chow W-H: Cancer rates among
lettuce and celery. J Agric Food Chem 1997;45:590–595. drinkers of black tea. Crit Rev Food Sci Nutr 1997;37:739–760.
10. Price KR, Bacon JR, Rhodes MJC: Effect of storage and domestic 29. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout
processing on the content and composition of flavonol glucosides D: Dietary antioxidant flavonoids and risk of coronary heart dis-
in onion (Allium cepa). J Agric Food Chem 1997;45:938–942. ease: The Zutphen Elderly Study. Lancet 1993;342:1007–1011.
11. Beecher GR: Overview of dietary flavonoids: Nomenclature, oc- 30. Hertog MGL, Feskens EJM, Kromhout D: Antioxidant flavonoids
currence and intake. J Nutr 2003;133(Suppl):3248S–3254S. and coronary heart disease risk. Lancet 1997;349:699.
12. Duthie GG, Gardner PT, Kyle JAM: Plant polyphenols: Are they 31. Hirvonen T, Pietinen P, Virtanen M, Ovaskainen M-L, Haekki-
the new magic bullet? Proc Nutr Soc 2003;62:599–603. nen S, Albanes D, Virtamo J: Intake of flavonols and flavones
13. Hertog MGL, Sweetnam PM, Fehily AM, Etwood PC, Kromhout and risk of coronary heart disease in male smokers. Epidemiol-
D: Antioxidant flavonols and ischemic heart disease in a Welsh ogy 2001;12:62–67.
population of men: The Caerphilly Study. Am J Clin Nutr 1997; 32. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R,
65:1489–1494. Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkoic S,
14. Knekt P, Isotupa S, Rissanen H, Helioevaara M, Jaervinen R, Pekkarinen M, Simic B, Toshima H, Feskens E, Hollman PCH,
Haekkinen S, Aromaa A, Reunanen A: Flavonoid intake and risk Katan MB: Flavonoid intake and long-term risk of coronary heart
of chronic diseases. Am J Clin Nutr 2002;76:560–568. disease and cancer in the Seven Countries Study. Arch Intern Med
15. Geleijnse JM, Launer LJ, van der Kuip DAM, Hofman A, Wit- 1995;155:381–386.
terman JCM: Inverse association of tea and flavonoid intakes with 33. Kyle J, McNeill G, Phillip M, Duthie G: Effects of adding milk
incident myocardial infarction: The Rotterdam Study. Am J Clin to black tea on plasma polyphenol concentrations and antioxidant
Nutr 2002;75:880–886. capacity of human volunteers. In: Proceedings of the 1st Inter-
16. Arts IC, Hollman PCH, Feskens EJ, Bueno de Mesquita HB, national Conference on Polyphenols and Health, November 2003,
Kromhout D: Catechin intake and associated dietary and lifestyle Vichy, France, P89.
factors in a representative sample of Dutch men and women. Eur 34. Hollman PCH, van Het Hof KH, Tijburg LB, Katan MB: Addi-
J Clin Nutr 2001;55:76–81. tion of milk does not affect the absorption of flavonols from tea
17. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC: Re- in man. Free Radic Res 2001;34:297–300.
lation between intake of flavonoids and risk for coronary heart dis- 35. van het Hof KH, Kivits GAA, Weststrate JA, Tijburg LBM:
ease in male health professionals. Ann Intern Med 1996;125:384–386. Bioavailability of catechins from tea: The effect of milk. Eur J
18. Sesso HD, Gaziano JM, Liu S, Buring JE: Flavonoid intake and Clin Nutr 1998;52:356–359.
the risk of cardiovascular disease in women. Am J Clin Nutr 36. Serafini M, Ghiselli A, Ferro-Luzzi A: In vivo antioxidant effect
2003;77:1400–1408. of green and black tea in man. Eur J Clin Nutr 1996;50:28–32.
19. Yochum L, Kushi LH, Meyer K, Aaron F: Dietary flavonoid in- 37. Keli SO, Hertog MGL, Feskens EJM, Kromhout D: Dietary
take and risk of cardiovascular disease in postmenopausal women. flavonoids, antioxidant vitamins and incidence of stroke. Arch In-
Am J Epidemiol 1999;149:943–949. tern Med 1996;154:637–642.
20. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae 38. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P: In-
N: Dietary intakes of flavonols, flavones and isoflavones by take of flavonoids, carotenoids, vitamins C and E, and risk of
Japanese women and the inverse correlation between quercetin stroke in male smokers. Stroke 2000;31:2301–2306.
intake and plasma LDL cholesterol concentration. J Nutr 39. Goldbohm RA, Hertog MGL, Brants HAM, van Poppl G, van den
2000;130:2243–2250. Brandt PA: Consumption of black tea and cancer risk: A prospec-
21. Linseisen J, Radtke J, Wolfram G: Flavonoid intake of adults in tive cohort study. J Natl Cancer Inst 1996;88:93–100.
a Bavarian subgroup of the national food consumption survey. Z 40. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout
Ernahrungswiss 1997;36:403–412. D: Dietary flavonoids and cancer risk in the Zutphen Elderly
22. Sellappan S, Akoh CC: Flavonoids and antioxidant capacity of Study. Nutr Cancer 1994;22:175–184.
Georgia-grown Vidalia onions. J Agric Food Chem 2002;50: 41. Garcia-Closas R, Gnzalez CA, Agudo A, Riboli E: Intake of spe-
5338–5342. cific carotenoids and flavonoids and the risk of gastric cancer in
23. USDA Database for the Flavonoid Content of Selected Foods— Spain. Cancer Causes Control 1999;10:71–82.
2003. http://www.nal.usda.gov/fnic/foodcomp/Data/Flav/flav.html 42. Garcia-Closas R, Agudo A, Gonzalez CA, Riboli E: Intake of spe-
(accessed March 2003). cific carotenoids and flavonoids and the risk of lung cancer in
24. Iowa State University Database on the Isoflavone Content of women in Barcelona, Spain. Nutr Cancer 1998;32:154–158.
Foods. http://www.nal.usda.gov/fnic/foodcomp/Data/isoflav.html 43. Le Marchand l, Murphy SP, Hankin JH, Wilkens LR, Kolonel
(accessed April 2004). LN: Intake of flavonoids and lung cancer. J Natl Cancer Inst
25. Adlercreutz H: Phytoestrogens and breast cancer. J Steroid 2000;92:154–160.
Biochem Mol Biol 2003;83:113–118. 44. De Stefani E, Brennan P, Boffetta P, Ronco AL, Mendilaharsu
26. Tham DM, Gardner CD, Haskell WL: Clinical review 97: Poten- M, Deneo-Pellegrini H: Vegetables, fruits, related dietary antiox-
tial health benefits of dietary phytoestrogens: A review of the idants and risk of squamous cell carcinoma of the esophagus: A
clinical, epidemiological, and mechanistic evidence. J Clin En- case control study in Uruguay. Nutr Cancer 2000;38:23–29.
docrinol Metab 1998;83:2223–2235. 45. Middleton E Jr, Kandaswami C, Theoharides TC: The effects of
27. Riemersma RA, Rice-Evans CA, Tyrell RM, Clifford MN, Lean plant flavonoids on mammalian cells: Implications for inflamma-
MEJ: Tea flavonoids and cardiovascular health. Q J Med 2001; tion, heart disease and cancer. Pharmacol Rev 2000;52:673–751.
94:277–282. 46. Price KR, Casuscelli R, Calquhoun IJ, Rhodes MJC: Composi-
290 GRAF ET AL.

tion and content of flavonol glycosides in broccoli florets (Bras- urine as biomarkers for dietary phytoestrogen intake and their re-
sica olearacea) and their fate during cooking. J Sci Food Agric lation to breast cancer risk in European Prospective Investigation
1998;77:468–472. of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers
47. Graefe EU, Wittig J, Mueller S, Riethling A-K, Uehleke B, Prev 2004;13:698–708.
Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M: Phar- 52. Nielsen SE, Freese R, Kleemola P, Mutanen M: Flavonoids in hu-
macokinetics and bioavailability of quercetin glycosides in hu- man urine as biomarkers for intake of fruits and vegetables. Can-
mans. J Clin Pharmacol 2001;41:492–499. cer Epidemiol Biomarkers Prev 2002;11:459–466.
48. Radtke J, Linseisen J, Wolfram G: Fasting plasma concentrations 53. Erlund I, Kosonen T, Alfthan G, Mäenpää J, Perttunen K, Ken-
of selected flavonoids as markers of their ordinary dietary intake. raali J, Parantainen J, Aro A: Pharmacokinetics of quercetin from
Eur J Nutr 2002;41:203–209. quercetin aglycone and rutin in healthy volunteers. Eur J Clin Nutr
49. Erlund I, Silaste ML, Alfthan G, Rantala M, Kesäniemi YA, Aro 2000;56:545–553.
A: Plasma concentrations of the flavonoids hesperetin, naringenin 54. Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction
and quercetin in human subjects following their habitual diets, and of dietary flavonol consumption from fasting plasma concentra-
diets high or low in fruit and vegetables. Eur J Clin Nutr tion or urinary excretion. Eur J Clin Nutr 2000;54:143–149.
2002;56:891–898. 55. deVries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL,
50. Dai Q, Franke AA, Jin F, Shu X-O, Hebert JR, Custer LJ, Cheng van Staveren WA, Katan MB: Plasma concentrations and urinary
J, Gao Y-T, Zheng W: Urinary excretion of phytoestrogens and excretion of the antioxidant flavonols quercetin and kaempferol
risk of breast cancer among Chinese women in Shanghai. Cancer as biomarkers for dietary intake. Am J Clin Nutr 1998;68:60–65.
Epidemiol Biomarkers Prev 2002;11:815–821. 56. Erlund I, Meririnne E, Alfthan G, Aro A: Plasma kinetics and uri-
51. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting nary excretion of the flavanones naringenin and hesperetin in hu-
NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, mans after ingestion of orange juice and grapefruit juice. J Nutr
Bingham SA: Phytoestrogen concentrations in serum and spot 2001;131:235–241.
This article has been cited by:

1. Sanaz Haratifar, Milena Corredig. 2014. Interactions between tea catechins and casein micelles and their impact on renneting
functionality. Food Chemistry 143, 27-32. [CrossRef]
2. Ghassan M. Sulaiman, Ahmed A. Al-Amiery, Renzo Bagnati. 2013. Theoretical, antioxidant and cytotoxic activities of caffeic
acid phenethyl ester and chrysin. International Journal of Food Sciences and Nutrition 1-5. [CrossRef]
3. Patrick Jonczyk, Meike Takenberg, Steffen Hartwig, Sascha Beutel, Ralf G. Berger, Thomas Scheper. 2013. Cultivation of shear
stress sensitive microorganisms in disposable bag reactor systems. Journal of Biotechnology 167:4, 370-376. [CrossRef]
4. Pon Velayutham Anandh Babu, Dongmin Liu, Elizabeth R. Gilbert. 2013. Recent advances in understanding the anti-diabetic
actions of dietary flavonoids. The Journal of Nutritional Biochemistry . [CrossRef]
5. N.F.L. Machado, L.A.E. Batista de Carvalho, J.C. Otero, M.P.M. Marques. 2013. A conformational study of hydroxylated
isoflavones by vibrational spectroscopy coupled with DFT calculations. Vibrational Spectroscopy 68, 257-265. [CrossRef]
6. Zehou Liu, Yaxi Liu, Zhien Pu, Jirui Wang, Youliang Zheng, Yanhong Li, Yuming Wei. 2013. Regulation, evolution, and
functionality of flavonoids in cereal crops. Biotechnology Letters . [CrossRef]
7. Guo Ma, Baojian Wu, Song Gao, Zhen Yang, Yong Ma, Ming Hu. 2013. Mutual Regioselective Inhibition of Human UGT1A1-
Mediated Glucuronidation of Four Flavonoids. Molecular Pharmaceutics 130717100421009. [CrossRef]
8. Kerrie L. Kaspar, Christina KhooCranberry Polyphenols in the Promotion of Urinary Tract, Cardiovascular and Emerging Health
Areas 273-292. [CrossRef]
9. Lindsay A. Wegiel, Lisa J. Mauer, Kevin J. Edgar, Lynne S. Taylor. 2013. Mid-infrared spectroscopy as a polymer selection tool
for formulating amorphous solid dispersions. Journal of Pharmacy and Pharmacology n/a-n/a. [CrossRef]
10. Nidhi Jaiswal, Dileep Kumar, Syed Ibrahim Rizvi. 2013. Red onion extract (Allium cepa L.) supplementation improves redox
balance in oxidatively stressed rats. Food Science and Human Wellness 2:2, 99-104. [CrossRef]
11. N.F.L. Machado, L.A.E. Batista de Carvalho, J.C. Otero, M.P.M. Marques. 2013. A conformational study of hydroxyflavones by
vibrational spectroscopy coupled to DFT calculations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 109,
116-124. [CrossRef]
12. Tugba Ozdal, Esra Capanoglu, Filiz Altay. 2013. A review on protein–phenolic interactions and associated changes. Food Research
International 51:2, 954-970. [CrossRef]
13. Eun A. Cho, Hyun Kyung Song, Sang-Hyeup Lee, Bong Hyun Chung, Heon Man Lim, Myung Kyu Lee. 2013. Differential
in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases. Journal of Cellular Biochemistry 114:4,
864-873. [CrossRef]
14. Silvia Wein, Eva Schrader, Gerald Rimbach, Siegfried Wolffram. 2013. Oral Green Tea Catechins Transiently Lower Plasma
Glucose Concentrations in Female db/db Mice. Journal of Medicinal Food 16:4, 312-317. [Abstract] [Full Text HTML] [Full
Text PDF] [Full Text PDF with Links]
15. Fereidoon Shahidi, Zhuliang TanRaisins: Processing, Phytochemicals, and Health Benefits 372-392. [CrossRef]
16. Vikas Garg, Ankit Kumar, Anurag Chaudhary, Saurabh Agrawal, Praveen Tomar, K. K. Sreenivasan. 2013. Synthesis, biological
evaluation and molecular docking studies of 1,3-benzoxazine derivatives as potential anticancer agents. Medicinal Chemistry Research
. [CrossRef]
17. Scott A. Robotham, Jennifer S. Brodbelt. 2013. Identification of Flavone Glucuronide Isomers by Metal Complexation
and Tandem Mass Spectrometry: Regioselectivity of Uridine 5′-Diphosphate–Glucuronosyltransferase Isozymes in the
Biotransformation of Flavones. Journal of Agricultural and Food Chemistry 130208093306000. [CrossRef]
18. Lisa M. Vislocky, Maria Luz Fernandez. 2013. Grapes and Grape Products. Nutrition Today 48:1, 47-51. [CrossRef]
19. Ran Yang, Lanlan Yu, Huajin Zeng, Ruiling Liang, Xiaolan Chen, Lingbo Qu. 2012. The Interaction of Flavonoid-Lysozyme
and the Relationship Between Molecular Structure of Flavonoids and Their Binding Activity to Lysozyme. Journal of Fluorescence
22:6, 1449-1459. [CrossRef]
20. Yusuf Ziya Doğru, Mustafa Erat. 2012. Investigation of some kinetic properties of polyphenol oxidase from parsley (Petroselinum
crispum, Apiaceae). Food Research International 49:1, 411-415. [CrossRef]
21. Ashutosh Pandey, Prashant Misra, K. Chandrashekar, Prabodh Kumar Trivedi. 2012. Development of AtMYB12-expressing
transgenic tobacco callus culture for production of rutin with biopesticidal potential. Plant Cell Reports 31:10, 1867-1876.
[CrossRef]
22. Javier García-Tirado, Cristina Rieger-Reyes, Pablo Saz-Peiró. 2012. Efecto de los flavonoides en la prevención del cáncer de
pulmón: revisión sistemática. Medicina Clínica 139:8, 358-363. [CrossRef]
23. Eliane Angst, Jenny L. Park, Aune Moro, Qing-Yi Lu, Xuyang Lu, Gang Li, Jonathan King, Monica Chen, Howard A. Reber,
Vay Liang W. Go, Guido Eibl, Oscar J. Hines. 2012. The Flavonoid Quercetin Inhibits Pancreatic Cancer Growth In Vitro and
In Vivo. Pancreas 1. [CrossRef]
24. J. Chen, Y. -P. Shi. 2012. Simultaneous determination of five flavonoids in <i>Saussurea mongolica</i> Franch by high-
performance liquid chromatography. Acta Chromatographica 24:3, 489-499. [CrossRef]
25. Heiying Jin, Qiang Leng, Chunbo Li, Heiying JinDietary flavonoid for preventing colorectal neoplasms . [CrossRef]
26. Kazuo Yamagata, Chika Tagawa, Hiroshi Matsufuji, Makoto Chino. 2012. Dietary apigenin regulates high glucose and hypoxic
reoxygenation-induced reductions in apelin expression in human endothelial cells. The Journal of Nutritional Biochemistry 23:8,
929-936. [CrossRef]
27. Marwa N. Abu-Aisheh, Mohammad S. Mustafa, Mustafa M. El-Abadelah, Randa G. Naffa, Said I. Ismail, Malek A. Zihlif,
Mutasem O. Taha, Mohammad S. Mubarak. 2012. Synthesis and biological activity assays of some new N1-(flavon-7-
yl)amidrazone derivatives and related congeners. European Journal of Medicinal Chemistry 54, 65-74. [CrossRef]
28. Eun-Ju Yang, Sang-In Kim, Sang-Yun Park, Han-Yeol Bang, Ji Hye Jeong, Jai-Hyun So, In-Koo Rhee, Kyung-Sik Song. 2012.
Fermentation enhances the in vitro antioxidative effect of onion (Allium cepa) via an increase in quercetin content. Food and
Chemical Toxicology 50:6, 2042-2048. [CrossRef]
29. Antonella Leone, Cristiano Longo, James E. Trosko. 2012. The chemopreventive role of dietary phytochemicals through gap
junctional intercellular communication. Phytochemistry Reviews 11:2-3, 285-307. [CrossRef]
30. Bill Gurley, Kim E. Fifer, Zöe GardnerPhytochemical Modulators of Human Drug Metabolism: Drug Interactions with Fruits,
Vegetables, and Botanical Dietary Supplements . [CrossRef]
31. Sarah Egert, Gerald Rimbach, Patricia Huebbe. 2012. ApoE genotype: from geographic distribution to function and responsiveness
to dietary factors. Proceedings of the Nutrition Society 1-15. [CrossRef]
32. Deqing Wang, Yuan Zhuang, Yaping Tian, Graham Neil Thomas, Mingzhong Ying, Brian Tomlinson. 2012. Study of the Effects
of Total Flavonoids of Astragalus on Atherosclerosis Formation and Potential Mechanisms. Oxidative Medicine and Cellular
Longevity 2012, 1-10. [CrossRef]
33. Patrick Jonczyk, Anne Schmidt, Ismet Bice, Mechthild Gall, Egon Gross, Jens-Michael Hilmer, Uwe Bornscheuer, Sascha
Beutel, Thomas Scheper. 2011. Strikt anaerobe Batch-Kultivierung von Eubacterium ramulus in einem neuartigen Einweg-
Beutelreaktorsystem. Chemie Ingenieur Technik n/a-n/a. [CrossRef]
34. Heiying Jin, Qiang Leng, Chunbo Li, Heiying JinDietary flavonoid for preventing colorectal neoplasma . [CrossRef]
35. Biswapathik Pahari, Sandipan Chakraborty, Pradeep K. Sengupta. 2011. Encapsulation of 3-hydroxyflavone in γ-cyclodextrin
nanocavities: Excited state proton transfer fluorescence and molecular docking studies. Journal of Molecular Structure . [CrossRef]
36. Yanna Zhu, Yinghui Zhang, Wenhua Ling, Dan Feng, Xiaoyi Wei, Chen Yang, Jing Ma. 2011. Fruit Consumption Is Associated
with Lower Carotid Intima-Media Thickness and C-Reactive Protein Levels in Patients with Type 2 Diabetes Mellitus. Journal
of the American Dietetic Association 111:10, 1536-1542. [CrossRef]
37. Xulu S, Owira PMO. 2011. NARINGIN AMELIORATES ATHEROGENIC DYSLIPIDEMIA BUT NOT
HYPERGLYCEMIA IN RATS WITH TYPE 1 DIABETES. Journal of Cardiovascular Pharmacology 1. [CrossRef]
38. Sarah Egert, Siegfried Wolffram, Beate Schulze, Peter Langguth, Eva Maria Hubbermann, Karin Schwarz, Berit Adolphi, Anja
Bosy-Westphal, Gerald Rimbach, Manfred James Müller. 2011. Enriched cereal bars are more effective in increasing plasma
quercetin compared with quercetin from powder-filled hard capsules. British Journal of Nutrition 1-8. [CrossRef]
39. Cai Hua Yang, Lan Tang, Chang Lv, Ling Ye, Bi Jun Xia, Ming Hu, Zhong Qiu Liu. 2011. Sulfation of selected mono-
hydroxyflavones by sulfotransferases in vitro: a species and gender comparison. Journal of Pharmacy and Pharmacology 63:7,
967-970. [CrossRef]
40. Sunan Wang, Kelly A. Meckling, Massimo F. Marcone, Yukio Kakuda, Rong Tsao. 2011. Can phytochemical antioxidant rich
foods act as anti-cancer agents?. Food Research International . [CrossRef]
41. Maria Björkman, Ingeborg Klingen, Andrew N.E. Birch, Atle M. Bones, Toby J.A. Bruce, Tor J. Johansen, Richard Meadow,
Jørgen Mølmann, Randi Seljåsen, Lesley E. Smart, Derek Stewart. 2011. Phytochemicals of Brassicaceae in plant protection and
human health – Influences of climate, environment and agronomic practice. Phytochemistry 72:7, 538-556. [CrossRef]
42. Yi-Yeong Jeong, Hye-Jin Park, Young-Woo Cho, Eun-Jin Kim, Gyu-Tae Kim, Yun-Ja Mun, Jong Deog Lee, Jung-Hye Shin,
Nak-Ju Sung, Dawon Kang, Jaehee Han. 2011. Aged Red Garlic Extract Reduces Cigarette Smoke Extract-induced Cell Death in
Human Bronchial Smooth Muscle Cells by Increasing Intracellular Glutathione Levels. Phytotherapy Research n/a-n/a. [CrossRef]
43. Rong Chen, Jian-Bo Wang, Xian-Qing Zhang, Jing Ren, Cheng-Ming Zeng. 2011. Green tea polyphenol epigallocatechin-3-
gallate (EGCG) induced intermolecular cross-linking of membrane proteins. Archives of Biochemistry and Biophysics 507:2, 343-349.
[CrossRef]
44. HUA YAO, WEIZHENG XU, XIANGLIN SHI, ZHUO ZHANG. 2011. Dietary Flavonoids as Cancer Prevention Agents.
Journal of Environmental Science and Health, Part C 29:1, 1-31. [CrossRef]
45. 2011. Antioxidant Activity in Water and Methanol Extracts from Korean Edible Wild Plants. Journal of the Korean Society of Food
Science and Nutrition 40:1, 29-36. [CrossRef]
46. M. M. Dias, N. F. L. Machado, M. P. M. Marques. 2011. Dietary chromones as antioxidant agents—the structural variable. Food
& Function . [CrossRef]
47. F. W. CollinsCHAPTER 10: Oat Phenolics: Biochemistry and Biological Functionality 157-217. [CrossRef]
48. Hongjing Guan, Lu Gao, Lihua Zhu, Ling Yan, Mingyue Fu, Changgui Chen, Xuan Dong, Lang Wang, Kai Huang, Hong
Jiang. 2011. Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation.
Journal of Cellular Biochemistry n/a-n/a. [CrossRef]
49. Tamara I. Vakulskaya, Lyudmila I. Larina, Alexander V. Vashchenko. 2011. Radical anions of flavonoids. Magnetic Resonance in
Chemistry n/a-n/a. [CrossRef]
50. Cristian Del Bo’, Daniela Martini, Stefano Vendrame, Patrizia Riso, Salvatore Ciappellano, Dorothy Klimis-Zacas, Marisa Porrini.
2010. Improvement of lymphocyte resistance against H2O2-induced DNA damage in Sprague–Dawley rats after eight weeks of
a wild blueberry (Vaccinium angustifolium)-enriched diet. Mutation Research/Genetic Toxicology and Environmental Mutagenesis
703:2, 158-162. [CrossRef]
51. Chien-Chung Chen, Wen-Hsing Ke, Li-Han Ceng, Chia-Wen Hsieh, Being-Sun Wung. 2010. Calcium- and phosphatidylinositol
3-kinase/Akt-dependent activation of endothelial nitric oxide synthase by apigenin. Life Sciences 87:23-26, 743-749. [CrossRef]
52. Saebyeol Jang, Rodney W Johnson. 2010. Can consuming flavonoids restore old microglia to their youthful state?. Nutrition
Reviews 68:12, 719-728. [CrossRef]
53. Ying Zhang, Ying Li, Can Cao, Jie Cao, Wei Chen, Yu Zhang, Cheng Wang, Jia Wang, Xin Zhang, Xiujuan Zhao. 2010. Dietary
Flavonol and Flavone Intakes and Their Major Food Sources in Chinese Adults. Nutrition and Cancer 62:8, 1120-1127. [CrossRef]
54. Lisa M Vislocky, Maria Luz Fernandez. 2010. Biomedical effects of grape products. Nutrition Reviews 68:11, 656-670. [CrossRef]
55. Gary Williamson, Arianna Carughi. 2010. Polyphenol content and health benefits of raisins☆. Nutrition Research 30:8, 511-519.
[CrossRef]
56. Andrea Masotti, Letizia Da Sacco, Gian Franco Bottazzo, Anna Alisi. 2010. Microarray Technology: A Promising Tool in
Nutrigenomics. Critical Reviews in Food Science and Nutrition 50:7, 693-698. [CrossRef]
57. Hironori Tsuchiya. 2010. Structure-dependent membrane interaction of flavonoids associated with their bioactivity. Food
Chemistry 120:4, 1089-1096. [CrossRef]
58. Raul Zamora-Ros, Cristina Andres-Lacueva, Rosa M. Lamuela-Raventós, Toni Berenguer, Paula Jakszyn, Aurelio Barricarte, Eva
Ardanaz, Pilar Amiano, Miren Dorronsoro, Nerea Larrañaga, Carmen Martínez, María J. Sánchez, Carmen Navarro, María D.
Chirlaque, María J. Tormo, J. Ramón Quirós, Carlos A. González. 2010. Estimation of Dietary Sources and Flavonoid Intake in
a Spanish Adult Population (EPIC-Spain). Journal of the American Dietetic Association 110:3, 390-398. [CrossRef]
59. Damian Plazuk, Siden Top, Anne Vessières, Marie-Aude Plamont, Michel Huché, Janusz Zakrzewski, Anna Makal, Krzysztof
Woźniak, Gérard Jaouen. 2010. Organometallic cyclic polyphenols derived from 1,2-(α-keto tri or tetra methylene) ferrocene show
strong antiproliferative activity on hormone-independent breast cancer cells. Dalton Transactions 39:32, 7444. [CrossRef]
60. Rainer Cermak, Silvia Wein, Siegfried Wolffram, Peter Langguth. 2009. Effects of the flavonol quercetin on the bioavailability of
simvastatin in pigs. European Journal of Pharmaceutical Sciences 38:5, 519-524. [CrossRef]
61. Wenwen Jiang, Junping Kou, Zhi Zhang, Boyang Yu. 2009. The effects of twelve representative flavonoids on tissue factor
expression in human monocytes: Structure-activity relationships. Thrombosis Research 124:6, 714-720. [CrossRef]
62. Yumen Hilal, Ulrich H. Engelhardt. 2009. A new myricetin-rhamnodiglucoside from Camellia sinensis. Natural Product Research
23:17, 1621-1629. [CrossRef]
63. David Whitcomb, Julia Greer. 2009. Germ-Line Mutations, Pancreatic Inflammation, and Pancreatic Cancer. Clinical
Gastroenterology and Hepatology 7:11, S29-S34. [CrossRef]
64. Bi-hui Jin, Ling-bo Qian, Shuai Chen, Jun Li, Hui-ping Wang, Iain C. Bruce, Jun Lin, Qiang Xia. 2009. Apigenin protects
endothelium-dependent relaxation of rat aorta against oxidative stress. European Journal of Pharmacology 616:1-3, 200-205.
[CrossRef]
65. Stevens M. Brumbley, Sandy J. Snyman, Annathurai Gnanasambandam, Priya Joyce, Scott R. Hermann, Jorge A.G. da Silva,
Richard B. McQualter, Ming-Li Wang, Brian T. Egan, Andrew H. Paterson, Henrick H. Albert, Paul H. MooreSugarcane .
[CrossRef]
66. Timothy L Dawson. 2009. Biosynthesis and synthesis of natural colours. Coloration Technology 125:2, 61-73. [CrossRef]
67. G. S. M. J. E. Duchateau, W. KlaffkeHealth food product composition, structure and bioavailability 647-662. [CrossRef]
68. Cédric Lecoutey, Christine Fossey, Luc Demuynck, François Lefoulon, Frédéric Fabis, Sylvain Rault. 2008. A convenient
microwave-assisted 5-amination of flavones. Tetrahedron 64:49, 11243-11248. [CrossRef]
69. N. Ceren Alemdaroglu, Ulrich Dietz, Siegfried Wolffram, Hildegard Spahn-Langguth, Peter Langguth. 2008. Influence of
green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability.
Biopharmaceutics & Drug Disposition 29:6, 335-348. [CrossRef]
70. Laura K. Stewart, Jeff L. Soileau, David Ribnicky, Zhong Q. Wang, Ilya Raskin, Alexander Poulev, Martin Majewski, William
T. Cefalu, Thomas W. Gettys. 2008. Quercetin transiently increases energy expenditure but persistently decreases circulating
markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 57, S39-S46. [CrossRef]
71. Eve Bralley, Phillip Greenspan, James L. Hargrove, Diane K. Hartle. 2008. Inhibition of Hyaluronidase Activity by Select Sorghum
Brans. Journal of Medicinal Food 11:2, 307-312. [Abstract] [Full Text PDF] [Full Text PDF with Links]
72. Xenofon Tzounis, Jelena Vulevic, Gunter G. C. Kuhnle, Trevor George, Jadwiga Leonczak, Glenn R. Gibson, Catherine Kwik-
Uribe, Jeremy P. E. Spencer. 2008. Flavanol monomer-induced changes to the human faecal microflora. British Journal of Nutrition
99:04. . [CrossRef]
73. L WILMS, J KLEINJANS, E MOONEN, J BRIEDE. 2008. Discriminative protection against hydroxyl and superoxide anion
radicals by quercetin in human leucocytes in vitro. Toxicology in Vitro 22:2, 301-307. [CrossRef]
74. Don Cipollini, Randall Stevenson, Stephanie Enright, Alieta Eyles, Pierluigi Bonello. 2008. Phenolic Metabolites in Leaves of
the Invasive Shrub, Lonicera maackii, and Their Potential Phytotoxic and Anti-Herbivore Effects. Journal of Chemical Ecology
34:2, 144-152. [CrossRef]
75. Jin-Taek Hwang, Dae Young Kwon, Ock Jin Park, Myung Sunny Kim. 2008. Resveratrol protects ROS-induced cell death by
activating AMPK in H9c2 cardiac muscle cells. Genes & Nutrition 2:4, 323-326. [CrossRef]
76. J PENNINGTON. 2008. Applications of food composition data: Data sources and considerations for use. Journal of Food
Composition and Analysis 21, S3-S12. [CrossRef]
77. S. Buchwald-Werner, C. Gärtner, P. Horlacher, G. SchwarzFortification with substances other than vitamins and minerals
(polyphenols, carotenoids, fatty acids and phytosterols) 41-59. [CrossRef]
78. Hyun Young Kim, Da Mi Jeong, Hee Jin Jung, Yu Jung Jung, Takako Yokozawa, Jae Sue Choi. 2008. Hypolipidemic Effects
of Sophora flavescens and Its Constituents in Poloxamer 407-Induced Hyperlipidemic and Cholesterol-Fed Rats. Biological &
Pharmaceutical Bulletin 31:1, 73-78. [CrossRef]
79. Rainer Cermak. 2008. Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opinion on Drug Metabolism
& Toxicology 4:1, 17-35. [CrossRef]
80. J PENNINGTON, P STUMBO, S MURPHY, S MCNUTT, A ELDRIDGE, B MCCABESELLERS, C CHENARD. 2007.
Food Composition Data: The Foundation of Dietetic Practice and Research. Journal of the American Dietetic Association 107:12,
2105-2113. [CrossRef]
81. G ROMAN. 2007. Autism: Transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and
to other environmental antithyroid agents. Journal of the Neurological Sciences 262:1-2, 15-26. [CrossRef]
82. Pamela Maher, Karmen F. Salgado, Justin A. Zivin, Paul A. Lapchak. 2007. A novel approach to screening for new neuroprotective
compounds for the treatment of stroke. Brain Research 1173, 117-125. [CrossRef]
83. Joaquim Maurício Duarte-Almeida, Alexis Vidal Novoa, Adyary Fallarero Linares, Franco M. Lajolo, Maria Inés Genovese.
2006. Antioxidant Activity of Phenolics Compounds From Sugar Cane (Saccharum officinarum L.) Juice. Plant Foods for Human
Nutrition 61:4, 187-192. [CrossRef]
84. Sidhartha D. Ray, Nirav Patel, Nilank Shah, Akila Nagori, Anne Naqvi, Sidney J. Stohs. 2006. Pre-exposure to a novel nutritional
mixture containing a series of phytochemicals prevents acetaminophen-induced programmed and unprogrammed cell deaths by
enhancing BCL-XL expression and minimizing oxidative stress in the liver. Molecular and Cellular Biochemistry 293:1-2, 119-136.
[CrossRef]
85. Jürgen Ehlting, Björn Hamberger, Rachel Million-Rousseau, Danièle Werck-Reichhart. 2006. Cytochromes P450 in phenolic
metabolism. Phytochemistry Reviews 5:2-3, 239-270. [CrossRef]
86. Barry Smith, Uma Gupta, B GuptaCaffeine, Physiology, Pathology, and Behavior 367-372. [CrossRef]
87. Christian Seitz, Christian Eder, Bettina Deiml, Sandra Kellner, Stefan Martens, Gert Forkmann. 2006. Cloning, Functional
Identification and Sequence Analysis of Flavonoid 3′-hydroxylase and Flavonoid 3′,5′-hydroxylase cDNAs Reveals Independent
Evolution of Flavonoid 3′,5′-hydroxylase in the Asteraceae Family. Plant Molecular Biology 61:3, 365-381. [CrossRef]
88. 2005. LiteratureWatch. Alternative and Complementary Therapies 11:6, 328-329. [Citation] [Full Text PDF] [Full Text PDF
with Links]

View publication stats